The STRIDE trial set out to answer a question that has been difficult to address in peripheral artery disease. Can anything meaningfully improve how far patients are able to walk? For years, exercise has remained the foundation of treatment. Patients are told to walk through discomfort to build collateral circulation. Some are able to do it. Many are not. The STRIDE trial focused on walking capacity. Led by Dr. Marc Bonaca at the University of Colorado School of Medicine, the

When someone is told they’ve run out of options, it’s usually not because nothing exists. It’s because the situation has gotten more complicated and the tools available to that doctor may be limited. That’s often the case with advanced peripheral artery disease, especially when it’s below the knee. At a recent medical meeting, doctors shared one-year results from Reflow Medical's study called DEEPER REVEAL. It looked at a different way to treat patients with chronic limb-thre

Highlighted at ISET 2026 by Dr. Andrew Holden If you have severe PAD affecting the arteries below the knee, your doctor has probably told you that this area is one of the hardest to treat. Traditional metal stents do not work well there. Balloon angioplasty alone often leads to the artery narrowing again within months. For a long time, patients and doctors were stuck in a frustrating cycle of procedures with no great long-term solution. That is starting to change. What Is a B

Fresh from ACC.26, March 2026 High blood pressure is one of the most common challenges for people living with PAD — and new research just presented at the American College of Cardiology's 2026 Scientific Session may explain why some patients can't get theirs under control, no matter how many medications they try. What the MOMENTUM Trial Found MOMENTUM screened over 1,000 patients with "resistant" hypertension, defined as blood pressure that remains above target despite taking

For years, the standard treatment for Peripheral Arterial Disease (PAD)—the narrowing of arteries in the legs—felt like a temporary fix. Doctors would use a small balloon (angioplasty) to open the artery, only for many patients to find themselves back in the hospital months later because the vessel had narrowed again. While previous research like the IMPACT study focused on measuring how well those balloons worked, a landmark study just released in late March 2026 has shif